Featured News

The SynCeD Study is looking for adult volunteers with celiac disease to join a phase 2a clinical trial. Your participation could make a difference. 

The Celiac Disease Foundation is proud to continue our partnership with the Boston Children's Hospital in presenting "Celiac Smarts," a live-streamed symposium for the health care and celiac patient communities. Recording available now.

We know traveling safely is a priority for our celiac disease community. To promote gluten-free vacation options, the Celiac Disease Foundation is pleased to continue our long-standing partnership with Celiac…

The Cribsiders Podcast on pediatric medicine recently released an episode with a special guest, Dr. Dale Lee from Seattle Children's Hospital, about the diagnosis and management of celiac disease.

The Celiac Disease Foundation is proud to continue our partnership with the Celiac Disease Center at Columbia University in presenting an annual free livestream international symposium, this year titled “Celiac Disease: On the Horizon”. Recording available now.

Research is pivotal to the mission of the Celiac Disease Foundation, and so I’m excited to provide you with an update on the groundbreaking findings of a recent study conducted for the European Union’s Joint Research Centre (JRC).

Want to get involved in celiac disease research? It’s time to take action. The TEV-CeD Study is a phase 1b clinical trial testing the investigational medication TEV-53408 for the treatment of celiac disease.  

New research indicates that a specific set of natural memory T cells, when triggered by gluten, rapidly become destructive and cause intestinal damage in celiac disease patients.

Congratulations to Celiac Disease Foundation research partner Takeda Pharmaceuticals and its Medical Director Dan Leffler on recent media attention for three potential celiac disease therapies.

This year, we are proud to acknowledge the outpouring of support we received during the month of May.